Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Metabolomics-driven Molecular Source Analysis for personalized medicine in children

Obiettivo

While recent advent empowered the new reality of holistic metabolic phenotyping, we are currently still unable to accurately determine the source(s) of the underlying metabolites. This is undoubtedly the main stumbling block in inferring causality to new biomarkers for disease prevention, prediction, and prognosis, particularly given the rapidly increasing burden of metabolic diseases. At the same time, conventional metabolomics methods do not meet the requirements for adoption in clinical practice. MeMoSA will address these issues by unraveling the source hierarchy of the gastrointestinal metabolome, ultimately enabling effective personalized treatments through longitudinal source modulation and follow-up. First, two workflows for 1. high-throughput comprehensive 2D metabolomics and lipidomics and, 2. rapid clinically applicable ambient ionization metabotyping, will be developed. Second, molecular fingerprints of our unique deeply phenotyped pediatric cohorts (1.5k children) will be generated and advanced machine learning algorithms will be used to predict metabolite abundances based on their sources, i.e. diet, lifestyle, anthropometrics, microbiome, drug intake, psychological factors, clinical markers, etc. Third, a combination of in vitro digestions, in vivo humanized mice, and in silico experiments with selected source variables will be designed to contribute to our understanding of source-metabolite causality. These mechanistic insights will be used to build dedicated intervention trials in children with specific source-dominated metabotypes. MeMoSA will lay the foundation for integrating metabolomics into personalized and preventive medicine in children through (i) better prediction of individual metabotypes in relation to health; (ii) in-depth insight into metabolite sources, which will foster a framework for biomarker qualification and unraveling disease etiology; (iii) greater treatment efficacy through dedicated metabolome-driven source modulation.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2023-COG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

UNIVERSITEIT GENT
Contributo netto dell'UE
€ 1 999 763,00
Indirizzo
SINT PIETERSNIEUWSTRAAT 25
9000 Gent
Belgio
Regione
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 999 763,00

Beneficiari (1)